Cetuximab in combination with methotrexate (MTX) as first-line treatment in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): A phase Ib randomized phase II study versus single agent MTX
Saved in:
Published in | Annals of oncology Vol. 29; p. viii381 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.10.2018
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0923-7534 1569-8041 |
---|---|
DOI: | 10.1093/annonc/mdy287.024 |